- Home
- CLRO vs MTVA Comparison
CLRO vs MTVA Comparison
Compare CLRO & MTVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRO
- MTVA
- Stock Information
- Founded
- CLRO 1983
- MTVA 2014
- Country
- CLRO United States
- MTVA United States
- Employees
- CLRO N/A
- MTVA N/A
- Industry
- CLRO Radio And Television Broadcasting And Communications Equipment
- MTVA
- Sector
- CLRO Technology
- MTVA
- Exchange
- CLRO Nasdaq
- MTVA NYSE
- Market Cap
- CLRO 12.5M
- MTVA 14.3M
- IPO Year
- CLRO N/A
- MTVA N/A
- Fundamental
- Price
- CLRO $10.99
- MTVA $0.70
- Analyst Decision
- CLRO
- MTVA Strong Buy
- Analyst Count
- CLRO 0
- MTVA 2
- Target Price
- CLRO N/A
- MTVA $7.50
- AVG Volume (30 Days)
- CLRO 2.1M
- MTVA 108.6K
- Earning Date
- CLRO 08-14-2025
- MTVA 08-13-2025
- Dividend Yield
- CLRO N/A
- MTVA N/A
- EPS Growth
- CLRO N/A
- MTVA N/A
- EPS
- CLRO N/A
- MTVA N/A
- Revenue
- CLRO $10,077,000.00
- MTVA N/A
- Revenue This Year
- CLRO N/A
- MTVA N/A
- Revenue Next Year
- CLRO N/A
- MTVA N/A
- P/E Ratio
- CLRO N/A
- MTVA N/A
- Revenue Growth
- CLRO N/A
- MTVA N/A
- 52 Week Low
- CLRO $4.35
- MTVA $0.60
- 52 Week High
- CLRO $21.00
- MTVA $5.16
- Technical
- Relative Strength Index (RSI)
- CLRO 70.47
- MTVA N/A
- Support Level
- CLRO $9.75
- MTVA N/A
- Resistance Level
- CLRO $11.44
- MTVA N/A
- Average True Range (ATR)
- CLRO 1.47
- MTVA 0.00
- MACD
- CLRO 0.63
- MTVA 0.00
- Stochastic Oscillator
- CLRO 59.96
- MTVA 0.00
About CLRO ClearOne Inc. (DE)
ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.
About MTVA METAVIA INC
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist for the treatment of obesity that is designed to be administered once weekly subcutaneously.